These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36194310)

  • 1. Short- and long-term outcomes of laparoscopic versus open pelvic exenteration for locally advanced rectal cancer: a single-center propensity score matching analysis.
    Tang J; Liu J; Du B; Zhang J; Zheng L; Wang X; Wan Y
    Tech Coloproctol; 2023 Jan; 27(1):43-52. PubMed ID: 36194310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Laparoscopic versus open pelvic exenteration for locally advanced rectal cancer: analysis of short- and long-term effects].
    Tang JQ; Zhang JZ; Mei SW; Hu G; Wan YL; Wang X; Wang XS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):253-259. PubMed ID: 36925125
    [No Abstract]   [Full Text] [Related]  

  • 3. Initial experience of laparoscopic pelvic exenteration and comparison with conventional open surgery.
    Uehara K; Nakamura H; Yoshino Y; Arimoto A; Kato T; Yokoyama Y; Ebata T; Nagino M
    Surg Endosc; 2016 Jan; 30(1):132-8. PubMed ID: 25795381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laparoscopic posterior pelvic exenteration is safe and feasible for locally advanced primary rectal cancer in female patients: a comparative study from China PelvEx collaborative.
    Zhuang M; Chen H; Li Y; Mei S; Liu J; Du B; Wang X; Wang X; Tang J
    Tech Coloproctol; 2023 Nov; 27(11):1109-1117. PubMed ID: 37243857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and long-term outcomes of laparoscopic versus open lateral lymph node dissection for locally advanced middle/lower rectal cancer using a propensity score-matched analysis.
    Watanabe J; Ishibe A; Suwa Y; Ozawa M; Nakagawa K; Suwa H; Ota M; Kunisaki C; Endo I
    Surg Endosc; 2021 Aug; 35(8):4427-4435. PubMed ID: 32875413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].
    Sun R; Cong L; Qiu HZ; Lin GL; Wu B; Niu BZ; Sun XY; Zhou JL; Xu L; Lu JY; Xiao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):522-530. PubMed ID: 35754217
    [No Abstract]   [Full Text] [Related]  

  • 7. Feasibility and safety of minimally invasive multivisceral resection for T4b rectal cancer: A 9-year review.
    Chan KS; Liu B; Tan MNA; How KY; Wong KY
    World J Gastrointest Surg; 2024 Mar; 16(3):777-789. PubMed ID: 38577068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in Surgical Outcomes and Quality-of-Life Outcomes in Pelvic Exenteration Between Locally Advanced Versus Locally Recurrent Rectal Cancers.
    Huang Y; Steffens D; Koh CE; Young JM; Solomon MJ
    Dis Colon Rectum; 2022 Dec; 65(12):1475-1482. PubMed ID: 35913831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic versus open rectal resection: a 1:2 propensity score-matched analysis of oncological adequateness, short- and long-term outcomes.
    Garbarino GM; Canali G; Tarantino G; Costa G; Ferri M; Balducci G; Pilozzi E; Berardi G; Mercantini P
    Int J Colorectal Dis; 2021 Apr; 36(4):801-810. PubMed ID: 33483843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic Pelvic Exenteration for Locally Advanced Rectal Cancer, Technique and Short-Term Outcomes.
    Pokharkar A; Kammar P; D'souza A; Bhamre R; Sugoor P; Saklani A
    J Laparoendosc Adv Surg Tech A; 2018 Dec; 28(12):1489-1494. PubMed ID: 29741977
    [No Abstract]   [Full Text] [Related]  

  • 11. Robotic versus open and laparoscopic pelvic exenterations for pelvic cancer: a multicenter propensity-matched analysis in Japan.
    Yatabe Y; Hanaoka M; Hanazawa R; Hirakawa A; Mukai T; Kimura K; Yamanoi K; Kono J; Yokota M; Takahashi H; Kobayashi A; Kobayashi K; Ichikawa N; Yasui M; Nakane K; Yamamoto M; Takenaka A; Nakamura Y; Takemasa I; Yabusaki N; Akamoto S; Tatarano S; Murata K; Manabe T; Fujimura T; Kawamura M; Egi H; Yamaguchi S; Terai Y; Inoue S; Ito A; Kinugasa Y
    Surg Endosc; 2024 Jun; ():. PubMed ID: 38886231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
    Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term oncologic outcomes of laparoscopic vs open surgery for stages II and III rectal cancer: A retrospective cohort study.
    Zhou ZX; Zhao LY; Lin T; Liu H; Deng HJ; Zhu HL; Yan J; Li GX
    World J Gastroenterol; 2015 May; 21(18):5505-12. PubMed ID: 25987773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally Invasive Surgery for Pelvic Exenteration in Primary Colorectal Cancer.
    Kumar NA; Sasi SP; Shinde RS; Verma K; Sugoor P; Desouza A; Engineer R; Saklani A
    JSLS; 2020; 24(3):. PubMed ID: 32714002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
    Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
    Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer.
    Bhangu A; Ali SM; Brown G; Nicholls RJ; Tekkis P
    Ann Surg; 2014 Feb; 259(2):315-22. PubMed ID: 23478530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of laparoscopic-assisted transanal pelvic exenteration in locally advanced rectal cancer with anterior invasion.
    Nonaka T; Tominaga T; Akazawa Y; Sawai T; Nagayasu T
    Tech Coloproctol; 2021 Jan; 25(1):69-74. PubMed ID: 32815047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic exenterations for primary rectal cancer: Analysis from a 10-year national prospective database.
    Pellino G; Biondo S; Codina Cazador A; Enríquez-Navascues JM; Espín-Basany E; Roig-Vila JV; García-Granero E;
    World J Gastroenterol; 2018 Dec; 24(45):5144-5153. PubMed ID: 30568391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
    Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel classification of posterior pelvic exenteration to assess prognosis in female patients with locally advanced primary rectal cancer: a retrospective cohort study from China PelvEx collaborative.
    Li Y; Zhuang M; Hu G; Zhang J; Qiu W; Mei S; Tang J
    Int J Colorectal Dis; 2024 Apr; 39(1):59. PubMed ID: 38664256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.